News
Superlative milestone for PSI/ETH spin-off Araris Biotech
PSI/ETH spin-off Araris Biotech AG, led by D-CHAB and ETH alumni, is being acquired by the multinational pharmaceutical company Taiho Pharmaceutical Co., Ltd. The total value of the deal comes to USD 1.14 billion.The scientific foundations for the company have been led in the group of professor and co-founder Roger Schibli (D-CHAB) at PSI.
Departures and Appointments at D-CHAB
Prof. Andrea Burden, Associate Professor of Pharmacoepidemiology will leave ETH Zurich at the end of May 2025 to take up a position at another university. Prof. Sereina Riniker is appointed as Full Professor of Computational Chemistry at D-CHAB. Sereina Riniker’s research is in the area of computational and theoretical chemistry, with a focus on developing new methods and software for molecular dynamics computer simulations and cheminformatics.
Peptide-based drugs without borders
Peptides act as signal mediators in the body and are on the rise as therapeutic agents. However, their full potential can often be limited by rapid degradation and elimination. Nathalie Grob, the new SNSF assistant professor for peptide-based drug discovery, is researching methods to circumvent these limitations and focuses her efforts on targeting diseases with no or unsatisfactory treatment options, primarily those affecting women and girls.